Received Feb 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
sick; This is a spontaneous report received from a Consumer or other non HCP. An 88-year-old female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Dupixent, start date: 08Apr2022, stop date: 06Nov2024, for atopic dermatitis unspecified, reaction(s): "walking issues", notes: solution for injection of strength 300mg/2ml at a dose of 300 mg QOW subcutaneous; Dupixent, start date: 08Apr2022, stop date: 06Nov2024, for atopic dermatitis unspecified, reaction(s): "gotten really sick", notes: solution for injection of strength 300mg/2ml at a dose of 300 mg QOW subcutaneous. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "sick". Additional information: Patient reported she had held off on taking Dupixent about 2 weeks ago due to getting a Covid shot. Patient stated it had made her very sick. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.